We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Non-Contrast MRI Effectively Monitors MS Patients

By MedImaging International staff writers
Posted on 03 Apr 2019
Print article
Image: Axial T1 MRIs obtained in 32-year-old woman with MS, with a new lesion (arrow) (Photo courtesy of TUM).
Image: Axial T1 MRIs obtained in 32-year-old woman with MS, with a new lesion (arrow) (Photo courtesy of TUM).
A new study suggests that magnetic resonance imaging (MRI) without contrast agent is just as effective as a contrast-enhanced approach for monitoring multiple sclerosis (MS) patients.

Researchers at Munich Technical University (TUM; Germany), SyNergy (Munich, Germany), and other institutions conducted a retrospective study of 359 patients with MS (mean age, 38.2 years) to examine whether the use of contrast agents has an effect on the detection of new or enlarged MS lesions and, consequently, the assessment of interval progression. For the study, 507 follow-up MRI T1-weighted images were assessed for new or enlarged lesions by two independent readers blinded to each other’s findings and to clinical information.

The primary outcome of the study was percentage of new or enlarged lesions detected only on contrast-enhanced T1-weighted images, and the assessment of interval progression, defined as at least one new or unequivocally enlarged lesion on follow-up MRI. The results revealed that of the 507 follow-up scans, 264 showed interval progression, with a total of 1,992 new or enlarged lesions. Assessment of interval progression did not differ significantly between the contrast-enhanced and non-enhanced MRI scans. The study was published on March 12, 2019, in Radiology.

“In over 500 follow-up scans, we missed only four of 1,992 new or enlarged lesions. Importantly, we did not miss disease activity in the non-enhanced scans in a single follow-up scan,” said senior author Benedikt Wiestler, MD, of TUM. “These factors warrant evaluation of strategies for reducing or omitting contrast agent, especially in MS patients who often accumulate a high number of MRI scans over their lifetimes.”

MRI with the administration of gadolinium-based contrast material is widely considered obligatory for follow-up scans of patients with MS. The researchers credited a proprietary approach developed at TUM that combines three dimensional (3D) MRI and algorithmic subtraction techniques tin order to cancel out unchanged areas in the follow-up MRI, with substantially improved visualization of new or enlarging white matter lesions seen in the study.

Related Links:
Munich Technical University
SyNergy

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Thyroid Shield
Standard Thyroid Shield
Under Table Shield
3 Section Double Pivot Under Table Shield
Radiology Software
MSK Radiology

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.